China SXT Pharmaceuticals Inc (SXTC) — Capital Reinvestment Ratio
China SXT Pharmaceuticals Inc (SXTC) has a Capital Reinvestment Ratio of 0.11x as of December 2022, meaning it reinvests 0% of its operating cash flow ($234.18K) in capital expenditures ($25.28K). Check China SXT Pharmaceuticals Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China SXT Pharmaceuticals Inc Capital Reinvestment Ratio (2016–2020)
This chart tracks China SXT Pharmaceuticals Inc's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see China SXT Pharmaceuticals Inc cash flow conversion.
Annual Capital Reinvestment Ratio for China SXT Pharmaceuticals Inc (2016–2020)
Year-by-year Capital Reinvestment Ratio for China SXT Pharmaceuticals Inc from 2016 to 2020. See China SXT Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.44x | $934.25K | $406.66K | ▼ -82.9% |
| 2019 | 2.55x | $239.19K | $610.09K | ▲ +366.1% |
| 2018 | 0.55x | $1.92 Million | $1.05 Million | ▼ -13.9% |
| 2017 | 0.64x | $293.04K | $186.31K | ▲ +19.6% |
| 2016 | 0.53x | $182.47K | $96.99K | — |